Pak pharma companies withhold payment of $430K of Indian exporters

he Central government has informed the Rajya Sabha that Pakistani pharmaceutical importers held back the payment of $430,000 of Indian exporters for pharmaceutical products exported to Pakistan from April to December 2021.

Indian pharma giants to spur towards an innovation movement

The inaugural session of the two-day FE Pharma Summit 2022 that began on Thursday, March 24th, focused on the theme of transitioning India from being the pharmacy of the world to evolving as an innovation hub.

Transition of Pharma Manufacturing towards Sustainability

The pharmaceutical industry has a substantial impact on the environment, especially when the materials used to make them and the chemicals that comprise make their way directly into the environment.

India's drugs regulator gives nod to clinical trial of Covid vaccine Covovax

The Drugs Controller General of India (DCGI) granted permission on Wednesday for conducting the phase-3 clinical trial of COVID-19 vaccine Covovax as a booster dose in adults, official sources said. The Subject Expert Committee (SEC) on COVID-19 .

Novavax to get COVID vaccine india authorisation for teens

Novavax Inc said on Tuesday its COVID-19 vaccine has got emergency-use authorization from the Drugs Controller General of India for children aged 12 to 17 years.

FutureCure Health obtains Rs 30 crore in series A funding

Health tech startup FutureCure Health has secured around USD 4 million (about Rs 30.4 crore) in series A funding round from RVCF India Growth Fund, Unicorn India Ventures, Kotak Investment Advisor Limited, and other investors,

TTK Healthcare to sell human pharma biz to Bharat Serums

Chennai-based TTK Healthcare is set to sell its human pharma division to Mumbai-based Bharat Serums and Vaccines (BSV) for Rs 805 crore. The board of TTK Healthcare accepted the sale on Monday as a going concern on a slump sale basis.

Sun to gain Daiichi's 11.28% stake in Zenotech

Sun Pharmaceutical Industries on Monday said it has entered into a share purchase agreement with Japan's Daiichi Sankyo Company to gain the latter's 11.28% stake in Zenotech Laboratories.

MPP signs deal with 35 generic manufacturers to produce generic versions of Pfizer's nirmatrelvir

The Medicines Patent Pool (MPP) recently declared that it has signed agreements with 35 companies, including Cadila Pharma, Torrent Pharma, Aurobindo Pharma, MSN Group, SMS Pharma, Granules India, to manufacture the generic version of Pfizer’s oral

U.S. FDA approves new Bristol Myers cancer immunotherapy

Bristol Myers Squibb Co said on Friday that U.S. regulators approved the first drug in a new class of cancer immunotherapies as an initial treatment for advanced melanoma, the deadliest form of skin cancer.

© 2025 India Pharma Outlook. All Rights Reserved.